Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| CHEK-ATP116 | Human | HEK293/Human NAPI-IIb Stable Cell Line |
Expression analysis of human NAPI-IIb on HEK293/Human NAPI-IIb Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human NAPI-IIb Stable Cell Line or negative control cell using anti-human NAPI-IIb antibody followed by PE anti-human IgG Fc antibody after fixation with 4% paraformaldehyde.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Upinitatug rilsodotin | XMT-1536 | Phase 2 Clinical | Mersana Therapeutics Inc, Adimab LLC | Ovarian Neoplasms; Cystadenocarcinoma, Serous; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
| YL-205 | YL205; YL-205 | Phase 2 Clinical | MediLink Therapeutics Co Ltd | Solid tumours | Details |
| TUB-040 | TUB-040 | Phase 2 Clinical | Tubulis GmbH | Ovarian Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
| AP-306 | EOS-789; AP-306 | Phase 2 Clinical | Chugai Pharmaceutical Co Ltd | Hyperphosphatemia; Nephrosis; Renal Insufficiency, Chronic | Details |
| Upinitatug rilsodotin | XMT-1536 | Phase 2 Clinical | Mersana Therapeutics Inc, Adimab LLC | Ovarian Neoplasms; Cystadenocarcinoma, Serous; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
| YL-205 | YL205; YL-205 | Phase 2 Clinical | MediLink Therapeutics Co Ltd | Solid tumours | Details |
| TUB-040 | TUB-040 | Phase 2 Clinical | Tubulis GmbH | Ovarian Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
| AP-306 | EOS-789; AP-306 | Phase 2 Clinical | Chugai Pharmaceutical Co Ltd | Hyperphosphatemia; Nephrosis; Renal Insufficiency, Chronic | Details |
This web search service is supported by Google Inc.
A-Z
